Vertigo, a common clinical symptom, presents as a perception of self or environmental movement, typically spinning, when there is no actual movement. It is a symptom rather than a standalone disease, often indicative of an underlying pathology. The symptom is commonly associated with diseases of the vestibular system, including peripheral and central vestibular disorders, but can also be a symptom of non-vestibular diseases.
As healthcare professionals, understanding and managing vertigo is crucial due to its prevalence and potential to significantly impair a patient's quality of life. This article aims to provide a comprehensive clinical approach to vertigo, aiding in its diagnosis, management, and treatment.
Vertigo is primarily a symptom of vestibular dysfunction. The vestibular system, which includes parts of the inner ear and brain, helps control balance and eye movements. If the system is damaged by disease, aging, or injury, vestibular disorders can result, leading to vertigo.
The sensation of vertigo can be subjective and objective. Subjective vertigo is when the patient feels as if they are moving. In contrast, objective vertigo is when the patient feels as if the surroundings are moving. Vertigo is often accompanied by other symptoms such as nausea, vomiting, sweating, and abnormal eye movements.
Vertigo can be classified into peripheral and central based on the location of the dysfunction within the vestibular pathway. Peripheral vertigo, the most common type, is due to a problem in the inner ear or vestibular nerve. Central vertigo is due to a problem in the brain, such as a stroke or tumor.
A comprehensive and systematic approach is essential in diagnosing vertigo. The first step is a thorough history taking and physical examination. The goal is to characterize the vertigo (onset, duration, triggers, associated symptoms), which can help differentiate peripheral from central vertigo.
Diagnostic tests such as electronystagmography (ENG), videonystagmography (VNG), and magnetic resonance imaging (MRI) may be used to confirm the diagnosis and identify the underlying cause. ENG and VNG are tests of the vestibular system, particularly useful in diagnosing peripheral vertigo. MRI is useful in diagnosing central vertigo as it can visualize the brain structures.
The treatment of vertigo depends on the underlying cause. For peripheral vertigo, treatment may include medications to reduce symptoms, vestibular rehabilitation therapy, or surgery in severe cases. For central vertigo, treatment involves managing the underlying brain condition.
Vestibular rehabilitation therapy is a form of physical therapy that uses specialized exercises that result in gaze and gait stabilization. Most are easy to perform and can be done at home. They work by promoting central nervous system compensation for inner ear deficits.
Medications such as meclizine, scopolamine, and diazepam can help relieve the symptoms of vertigo. However, these medications should not be used long term as they can impede the brain's compensation mechanisms.
Vertigo is a common clinical symptom that can significantly impair a patient's quality of life. As healthcare professionals, a comprehensive understanding of vertigo, its classification, diagnosis, and management strategies, is crucial in providing effective patient care. While the diagnosis and management of vertigo can be challenging, a systematic approach and the use of appropriate diagnostic tools can aid in the effective management of this condition.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation